Idiopathic Hypertensive Anal Canal: a Place of Internal Sphincterotomy
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
Idiopathic hypertensive anal canal is a fact and already exists presented by anal pain aggravated by defecation. It can be managed safely by closed lateral sphincterotomy but chemical sphincterotomy had a minor role in its management.
| Condition | Intervention |
|---|---|
|
Hypertensive Anal Canal |
Procedure: lateral internal sphincterotomy (LIS) Drug: Glycerin trinitrate (GTN) Drug: botulinum toxin injection (BTX A) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Idiopathic Hypertensive Anal Canal: a Place of Internal Sphincterotomy |
- Effect of Closed Lateral Sphincterotomy and Chemical Sphincterotomy on Hypertensive Anal Canal [ Time Frame: one year ] [ Designated as safety issue: Yes ]
- Relieve of Anal Pain [ Time Frame: one year after the procedure ] [ Designated as safety issue: Yes ]
| Enrollment: | 63 |
| Study Start Date: | September 2002 |
| Study Completion Date: | May 2008 |
| Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: surgical group lateral sphincterotomy
underwent closed lateral internal sphincterotomy (LIS) under local anesthesia at 3 o'clock in lithotomy position reaching up to the dentate line.
|
Procedure: lateral internal sphincterotomy (LIS)
closed lateral internal sphincterotomy was done under local anesthesia at 3 o'clock in lithotomy position reaching up to the dentate line.
Other Name: lateral INTERNAL sphincterotomy (LIS)
|
|
Active Comparator: Glycerin trinitrate group
all were instructed to apply the Glycerin trinitrate group (GTN) ointment 0.2 % twice a day to the edge and just inside the anal canal for 8 week course.
|
Drug: Glycerin trinitrate (GTN)
All were instructed to apply the GTN ointment 0.2 % twice a day to the edge and just inside the anal canal for 8 week course.
Other Name: GTN ointment
|
|
Active Comparator: botulinum toxin injection
All were injected with botulinum toxin injection (BTX- A) in the left lateral position; anesthesia was not required. A volume of 0.5 ml of dissolved toxin, i.e., 100 u Dysport, is injected in each patient. The injection is given with an insulin syringe fitted with a needle size of 21 gauze and 3.75 lengths. Injection into the IAS, with the patients awake in the left -lateral position in the outpatient clinic in the 3 and 9 o'clock position.
|
Drug: botulinum toxin injection (BTX A)
All were injected with botulinum toxin injection (BTX- A) in the left lateral position; anesthesia was not required. A volume of 0.5 ml of dissolved toxin, i.e., 100 u Dysport, is injected in each patient. The injection is given with an insulin syringe fitted with a needle size of 21 gauze and 3.75 lengths. Injection into the IAS, with the patients awake in the left -lateral position in the outpatient clinic in the 3 and 9 o'clock position.
Other Name: BTX A
|
Detailed Description:
Patient and methods: Sixty three patients complaining of anal pain without any anal pathology and 10 healthy volunteers were examined. All patients underwent clinical evaluation, neurological examination, anorectal manometry, and measurement of pudendal nerve terminal motor latency (PNTML). All patients with hypertensive anal canal were randomized into three groups. Group I (surgical group) underwent closed lateral sphincterotomy LS, group II using nitroglycerine ointment (GTN) and group III received injection of botulinum toxin in internal sphincter. Post procedures data were recorded at follow up period.
Eligibility| Ages Eligible for Study: | 18 Years to 61 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- all patients with hypertensive anal canal
Exclusion Criteria:
- patients who had any pathological anorectal lesions such as anal fissure, piles, rectal prolapse, intussusception, anismus, cancer, patients with normal anal pressure
- patients who previously had anorectal surgery, chemical or surgical sphincterotomy, anal dilatation, IBD, venereal disease, neurological disorder or systemic gastrointestinal disease
Contacts and Locations
More Information
Publications:
| Responsible Party: | ayman el nakeeb, Mansoura University hospital |
| ClinicalTrials.gov Identifier: | NCT00927849 History of Changes |
| Other Study ID Numbers: | hypertensive anal canal |
| Study First Received: | March 23, 2009 |
| Results First Received: | March 23, 2009 |
| Last Updated: | May 7, 2009 |
| Health Authority: | Egypt: Institutional Review Board |
Keywords provided by Mansoura University:
|
anal hypertonia sphincterotomy incontinence manometry |
Additional relevant MeSH terms:
|
Botulinum Toxins Glycerol Anti-Dyskinesia Agents Central Nervous System Agents Therapeutic Uses |
Pharmacologic Actions Cryoprotective Agents Protective Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on June 13, 2013